Macrophage Activation Syndrome Secondary to Histoplasmosis in an Adult Female Carrier of X-linked Chronic Granulomatous Disease with Extreme Lyonization
Abstract
not applicable to a Letter to the Editor
1. Blancas-Galicia L, Santos-Chavez E, Deswarte C, Mignac Q, Medina-Vera I, Leon-Lara X, et al. Genetic, Immunological, and Clinical Features of the First Mexican Cohort of Patients with Chronic Granulomatous Disease. J Clin Immunol. 2020;40(3):475-93.
2. Battersby AC, Braggins H, Pearce MS, Cale CM, Burns SO, Hackett S, et al. Inflammatory and autoimmune manifestations in X-linked carriers of chronic granulomatous disease in the United Kingdom. J Allergy Clin Immunol. 2017;140(2):628-30 e6.
3. Chiriaco M, Salfa I, Ursu GM, Cifaldi C, Di Cesare S, Rossi P, et al. Immunological Aspects of X-Linked Chronic Granulomatous Disease Female Carriers. Antioxidants (Basel). 2021;10(6).
4. Marciano BE, Zerbe CS, Falcone EL, Ding L, DeRavin SS, Daub J, et al. X-linked carriers of chronic granulomatous disease: Illness, lyonization, and stability. J Allergy Clin Immunol. 2018;141(1):365-71.
5. Laniado-Laborin R. Coccidioidomycosis and other endemic mycoses in Mexico. Rev Iberoam Micol. 2007;24(4):249-58.
6. Newman SL, Gootee L, Gabay JE. Human neutrophil-mediated fungistasis against Histoplasma capsulatum. Localization of fungistatic activity to the azurophil granules. J Clin Invest. 1993;92(2):624-31.
7. van de Geer A, Nieto-Patlan A, Kuhns DB, Tool AT, Arias AA, Bouaziz M, et al. Inherited p40phox deficiency differs from classic chronic granulomatous disease. J Clin Invest. 2018;128(9):3957-75.
8. Vignesh P, Loganathan SK, Sudhakar M, Chaudhary H, Rawat A, Sharma M, et al. Hemophagocytic Lymphohistiocytosis in Children with Chronic Granulomatous Disease-Single-Center Experience from North India. J Allergy Clin Immunol Pract. 2021;9(2):771-82 e3.
9. Alvarez-Cardona A, Rodriguez-Lozano AL, Blancas-Galicia L, Rivas-Larrauri FE, Yamazaki-Nakashimada MA. Intravenous immunoglobulin treatment for macrophage activation syndrome complicating chronic granulomatous disease. J Clin Immunol. 2012;32(2):207-11.
10. Urriola N, Williams A, Keat K. Macrophage activation syndrome/haemophagocytic lymphohistiocytosis secondary to Burkholderia cepacia complex septicaemia in an elderly female carrier of X-linked chronic granulomatous disease with extreme lyonisation: 'cepacia syndrome' revisited. BMJ Case Rep. 2019;12(8).
11. Jabr R, El Atrouni W, Male HJ, Hammoud
KA. Histoplasmosis- Associated Hemophagocytic Lymphohistiocytosis: A Review of the Literature. Can J Infect Dis Med Microbiol. 2019;2019:7107326.
12. Battersby A, Goldblatt D. Clinical manifestations in X-linked carriers of chronic granulomatous disease. In: Seger R, Roos D, B S, Kuijpers T, editors. Chronic Granulomatous Disease, Genetics, Biology and Clinical Management. 1. New York: Nova Science Publishers; 2017. p. 204-29.
13. Tsilifis C, Torppa T, Williams EJ, Albert MH, Hauck F, Soncini E, et al. Allogeneic HSCT for Symptomatic Female X-linked Chronic Granulomatous Disease Carriers. J Clin Immunol. 2023.
2. Battersby AC, Braggins H, Pearce MS, Cale CM, Burns SO, Hackett S, et al. Inflammatory and autoimmune manifestations in X-linked carriers of chronic granulomatous disease in the United Kingdom. J Allergy Clin Immunol. 2017;140(2):628-30 e6.
3. Chiriaco M, Salfa I, Ursu GM, Cifaldi C, Di Cesare S, Rossi P, et al. Immunological Aspects of X-Linked Chronic Granulomatous Disease Female Carriers. Antioxidants (Basel). 2021;10(6).
4. Marciano BE, Zerbe CS, Falcone EL, Ding L, DeRavin SS, Daub J, et al. X-linked carriers of chronic granulomatous disease: Illness, lyonization, and stability. J Allergy Clin Immunol. 2018;141(1):365-71.
5. Laniado-Laborin R. Coccidioidomycosis and other endemic mycoses in Mexico. Rev Iberoam Micol. 2007;24(4):249-58.
6. Newman SL, Gootee L, Gabay JE. Human neutrophil-mediated fungistasis against Histoplasma capsulatum. Localization of fungistatic activity to the azurophil granules. J Clin Invest. 1993;92(2):624-31.
7. van de Geer A, Nieto-Patlan A, Kuhns DB, Tool AT, Arias AA, Bouaziz M, et al. Inherited p40phox deficiency differs from classic chronic granulomatous disease. J Clin Invest. 2018;128(9):3957-75.
8. Vignesh P, Loganathan SK, Sudhakar M, Chaudhary H, Rawat A, Sharma M, et al. Hemophagocytic Lymphohistiocytosis in Children with Chronic Granulomatous Disease-Single-Center Experience from North India. J Allergy Clin Immunol Pract. 2021;9(2):771-82 e3.
9. Alvarez-Cardona A, Rodriguez-Lozano AL, Blancas-Galicia L, Rivas-Larrauri FE, Yamazaki-Nakashimada MA. Intravenous immunoglobulin treatment for macrophage activation syndrome complicating chronic granulomatous disease. J Clin Immunol. 2012;32(2):207-11.
10. Urriola N, Williams A, Keat K. Macrophage activation syndrome/haemophagocytic lymphohistiocytosis secondary to Burkholderia cepacia complex septicaemia in an elderly female carrier of X-linked chronic granulomatous disease with extreme lyonisation: 'cepacia syndrome' revisited. BMJ Case Rep. 2019;12(8).
11. Jabr R, El Atrouni W, Male HJ, Hammoud
KA. Histoplasmosis- Associated Hemophagocytic Lymphohistiocytosis: A Review of the Literature. Can J Infect Dis Med Microbiol. 2019;2019:7107326.
12. Battersby A, Goldblatt D. Clinical manifestations in X-linked carriers of chronic granulomatous disease. In: Seger R, Roos D, B S, Kuijpers T, editors. Chronic Granulomatous Disease, Genetics, Biology and Clinical Management. 1. New York: Nova Science Publishers; 2017. p. 204-29.
13. Tsilifis C, Torppa T, Williams EJ, Albert MH, Hauck F, Soncini E, et al. Allogeneic HSCT for Symptomatic Female X-linked Chronic Granulomatous Disease Carriers. J Clin Immunol. 2023.
| Files | ||
| Issue | Vol 22 No 6 (2023) | |
| Section | Letter to the Editor | |
| DOI | https://doi.org/10.18502/ijaai.v22i6.14650 | |
| Keywords | ||
| No Keywords No Keyword | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
León-Lara X, García-Pavón Osorio S, Espinosa Padilla S, Blancas-Galicia L. Macrophage Activation Syndrome Secondary to Histoplasmosis in an Adult Female Carrier of X-linked Chronic Granulomatous Disease with Extreme Lyonization. Iran J Allergy Asthma Immunol. 2023;22(6):609-612.
